Remove Clinical Development Remove Clinical Research Remove Life Science Remove Nurses
article thumbnail

The Benefits of Working for a Rapidly Growing Global Clinical Research Organization (CRO) like Medpace

XTalks

A clinical research organization (CRO) is a company that delivers outsourced services to plan, manage and execute clinical trials for biotechnology, pharmaceutical, and medical device companies. Read on to learn why life science and clinical research professionals are choosing a career with Medpace.

article thumbnail

“Nothing scares us” – Ukraine’s clinical research sector begins fearless recovery

Drug Discovery World

Following the news that the number of clinical trial recruiting sites in Ukraine has dropped by half since the Russian invasion, DDW’s Diana Spencer examines clinical trial data from analytics company Phesi and speaks to Dr Olena Karpenko , Clinical Research Director at Medical Center Ok!Clinic+ Dr Olena Karpenko.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cardiac Biomarkers in Cardiovascular Clinical Trials: Caveats and Considerations

XTalks

Liz Moore, DNP, advanced clinical nurse practitioner at Medpace, says that until the future of cardiac biomarkers arrives, CV clinical trials will have to continue to include and learn from the current markers. Full-Service Clinical Development. Mitigating Risk and the Patient Experience.

article thumbnail

Reaching for the gold standard of lung cancer screening

pharmaphorum

Once an eligible patient registers their interest in the service, a specially trained respiratory nurse will conduct an initial phone assessment. If the patient is deemed at high risk of developing lung cancer, they are offered a low dose CT scan to further investigate their lung health.

article thumbnail

COVID-19 Pandemic Coverage

XTalks

That said, the percentage of all COVID-19 deaths that occurred in nursing homes, standing at 81 percent, is the highest in the world followed by Spain at 66 percent. Yale hospital administrators bought about 1,200 reusable silicone masks and started distributing them to local doctors, nurses and respiratory therapists.